Status:
COMPLETED
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups
Lead Sponsor:
Mary Radomski
Conditions:
Breast Cancer
Breast Neoplasm
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense o...
Eligibility Criteria
Inclusion
- Able to attend intervention sessions for 9 weeks on Monday or Tuesday afternoons (4:30 - 6:30 pm) starting Monday, April 5, 2021
- 25 years of age or older
- Completed chemotherapy and/or radiation treatment for Stage 0, 1, 2, or 3 breast cancer at least 2 months prior to participating in the Compass Course intervention
- English speaking
- Graduated from high school
- Able to see, hear, speak (with or without assistive devices)
- Able to provide own transportation to sessions
- Willing and able to commit to attend all 8 intervention sessions
- Access to computer or tablet and adequate internet connection to participate in video conference
Exclusion
- Stage 4 breast cancer or any other cancer
- Actively receiving chemotherapy or radiation treatments for cancer. (However, patients may be on Herceptin and/or endocrine treatment and participate in the study.)
- History of neurologic disorder (such as stroke or brain injury) with residual impairments that likely interfere with learning
- Any medical condition (physical or mental health) that interferes with the performance of everyday activities and roles.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 7 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04767464
Start Date
March 1 2021
End Date
November 7 2023
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States, 55447